|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
World Health Organization (WHO), .
International agency for research on cancer. Global Cancer
Observatory: Cancer Today. WHO; Geneva: 2022, https://gco.iarc.who.int/media/globocan/factsheets/populations/160-china-fact-sheet.pdfMarch
10–2025
|
|
3
|
Bao H, Zhang L and Wang L, Zhang M, Zhao
Z, Fang L, Cong S, Zhou M and Wang L: Significant variations in the
cervical cancer screening rate in China by individual-level and
geographical measures of socioeconomic status: A multilevel model
analysis of a nationally representative survey dataset. Cancer Med.
7:2089–2100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Small W Jr, Bacon MA, Bajaj A, Chuang LT,
Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR,
Viswanathan AN and Gaffney DK: Cervical cancer: A global health
crisis. Cancer. 123:2404–2412. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cohen PA, Jhingran A, Oaknin A and Denny
L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carlton JG, Caballe A, Agromayor M, Kloc M
and Martin-Serrano J: ESCRT-III governs the Aurora B-mediated
abscission checkpoint through CHMP4C. Science. 336:220–225. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sadler JBA, Wenzel DM, Williams LK,
Guindo-Martínez M, Alam SL, Mercader JM, Torrents D, Ullman KS,
Sundquist WI and Martin-Serrano J: A cancer-associated polymorphism
in ESCRT-III disrupts the abscission checkpoint and promotes genome
instability. Proc Natl Acad Sci USA. 115:E8900–E8908. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nikolova DN, Doganov N, Dimitrov R,
Angelov K, Low SK, Dimova I, Toncheva D, Nakamura Y and Zembutsu H:
Genome-wide gene expression profiles of ovarian carcinoma:
Identification of molecular targets for the treatment of ovarian
carcinoma. Mol Med Rep. 2:365–384. 2009.PubMed/NCBI
|
|
10
|
Fujita K, Kume H, Matsuzaki K, Kawashima
A, Ujike T, Nagahara A, Uemura M, Miyagawa Y, Tomonaga T and
Nonomura N: Proteomic analysis of urinary extracellular vesicles
from high Gleason score prostate cancer. Sci Rep. 7:429612017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tommasino M: The human papillomavirus
family and its role in carcinogenesis. Semin Cancer Biol. 26:13–21.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Narisawa-Saito M and Kiyono T: Basic
mechanisms of high-risk human papillomavirus-induced
carcinogenesis: Roles of E6 and E7 proteins. Cancer Sci.
98:1505–1511. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miyashita T, Krajewski S, Krajewska M,
Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC: Tumor
suppressor p53 is a regulator of bcl-2 and bax gene expression in
vitro and in vivo. Oncogene. 9:1799–1805. 1994.PubMed/NCBI
|
|
15
|
Harden ME, Prasad N, Griffiths A and
Munger K: Modulation of microRNA-mRNA target pairs by human
papillomavirus 16 oncoproteins. mBio. 8:e02170–16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Norden C, Mendoza M, Dobbelaere J,
Kotwaliwale CV, Biggins S and Barral Y: The NoCut pathway links
completion of cytokinesis to spindle midzone function to prevent
chromosome breakage. Cell. 125:85–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Capalbo L, Montembault E, Takeda T, Bassi
ZI, Glover DM and D'Avino PP: The chromosomal passenger complex
controls the function of endosomal sorting complex required for
transport-III Snf7 proteins during cytokinesis. Open Biol.
2:1200702012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li K, Liu J, Tian M, Gao G, Qi X, Pan Y,
Ruan J, Liu C and Su X: CHMP4C disruption sensitizes the human lung
cancer cells to irradiation. Int J Mol Sci. 17:182015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM,
Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, et
al: GWAS meta-analysis and replication identifies three new
susceptibility loci for ovarian cancer. Nat Genet. 45:362–370.
370e1-22013. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Y and Yu X: Regulation of apoptosis:
The ubiquitous way. FASEB J. 17:790–799. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chipuk JE, Moldoveanu T, Llambi F, Parsons
MJ and Green DR: The BCL-2 family reunion. Mol Cell. 37:299–310.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ter Harmsel B, Smedts F, Kuijpers J,
Jeunink M, Trimbos B and Ramaekers F: BCL-2 immunoreactivity
increases with severity of CIN: A study of normal cervical
epithelia, CIN, and cervical carcinoma. J Pathol. 179:26–30. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dimitrakakis C, Kymionis G, Diakomanolis
E, Papaspyrou I, Rodolakis A, Arzimanoglou I, Leandros E and
Michalas S: The possible role of p53 and bcl-2 expression in
cervical carcinomas and their premalignant lesions. Gynecol Oncol.
77:129–136. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC,
Hwang JI, Chung CW, Jung YK and Oh BH: An anti-apoptotic protein
human survivin is a direct inhibitor of caspase-3 and −7.
Biochemistry. 40:1117–1123. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen X, Duan N, Zhang C and Zhang W:
Survivin and tumorigenesis: Molecular mechanisms and therapeutic
strategies. J Cancer. 7:314–323. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin SL, Wang M, Cao QQ and Li Q: Chromatin
modified protein 4C (CHMP4C) facilitates the malignant development
of cervical cancer cells. FEBS Open Bio. 10:1295–1303. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Crosbie EJ, Einstein MH, Franceschi S and
Kitchener HC: Human papillomavirus and cervical cancer. Lancet.
382:889–899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Muñoz N, Bosch FX, de Sanjosé S, Herrero
R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ;
International Agency for Research on Cancer Multicenter Cervical
Cancer Study Group, : Epidemiologic classification of human
papillomavirus types associated with cervical cancer. N Engl J Med.
348:518–527. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Smith JS, Lindsay L, Hoots B, Keys J,
Franceschi S, Winer R and Clifford GM: Human papillomavirus type
distribution in invasive cervical cancer and high-grade cervical
lesions: A meta-analysis update. Int J Cancer. 121:621–632. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Davis BN and Hata A: Regulation of
MicroRNA biogenesis: A miRiad of mechanisms. Cell Commun Signal.
7:182009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu X, Gan L and Zhang J: miR-543
inhibites cervical cancer growth and metastasis by targeting TRPM7.
Chem Biol Interact. 302:83–92. 2019. View Article : Google Scholar : PubMed/NCBI
|
